Therefore researchers recommend more studies are needed on how B12 may affect weight
Chadda KR, Cheng TS, Ong KK (2021) GLP-1 agonists for obesity and type 2 diabetes in children: Systematic review and meta-analysis
The tissue-specific receptor sensitisation is likely why BPC-157 does not carry the off-target hormonal effects seen with GH-axis compounds
Figure 2: Changes in body weight from baseline to the end of treatment at week 26 associated with the treatment policy estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo
Renal function should be assessed before starting treatment and monitored regularly, particularly during illness or dehydration